Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
DMK6W0
|
|||
Drug Name |
Emodepside
|
|||
Synonyms |
UNII-YZ647Y5GC9; 155030-63-0; Bay-44-4400; YZ647Y5GC9; CHEBI:78739; (3S,6R,9S,12R,15S,18R,21S,24R)-3,9,15,21-tetraisobutyl-4,6,10,16,18,22-hexamethyl-12,24-bis(4-morpholinobenzyl)-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclotetracosan-2,5,8,11,14,17,20,23-octaone; PF-1022-221; Cyclo((R)-lactoyl-N-methyl-L-leucyl-(R)-3-(p-morpholinophenyl)lactoyl-N-methyl-L-leucyl-(R)-lactoyl-N-methyl-L-leucyl-(R)-3-(p-morpholinophenyl)lactoyl-N-methyl-L-leucyl); Emodepside [INN]; emodepsida; emodepsidum; cyclo[(R)-lactoyl-N-methyl-L-leucyl-(R)-3-(p-morpholinophenyl)lactoyl-N-methyl-L-leucyl-(R)-lactoyl-N-methyl-L-leucyl-(R)-3-(p-morpholinophenyl)lactoyl-N-methyl-L-leucyl]; SCHEMBL167580; CHEMBL2104404; DTXSID50165799; DB11403; NCGC00507682-01; AC-31930; PF 1022-221; C18390; Q1339032; (3S,6R,9S,12R,15S,18R,21S,24R)-3,9,15,21-tetraisobutyl-4,6,10,16,18,22-hexamethyl-12,24-bis[4-(morpholin-4-yl)benzyl]-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclotetracosane-2,5,8,11,14,17,20,23-octone; cyclo [D-2-hydroxypropanoyl-N-methyl-L-leucyl-3-[4-(4-morpholinyl)phenyl]-D-2-hydroxypropanoyl-N-methyl-L-leucyl-D-2-hydroxypropanoyl-N-methyl-L-leucyl-3-[4-(4-morpholinyl)phenyl]-D-2-hydroxypropanoyl-N-methyl-L-leucyl]; cyclo {D-lactoyl-N-methyl-L-leucyl-3-[4-(4-morpholinyl)phenyl]-D-lactoyl-N-methyl-L-leucyl-D-lactoyl-N-methyl-L-leucyl-3-[4-(4-morpholinyl)phenyl]-D-lactoyl-N-methyl-L-leucyl}
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Filarial disease [ICD-11: 1F66] | Phase 1 | [1] | |
Company |
Bayer; Drugs for Neglected Diseases Initiative
|
|||
Structure |
Download2D MOL
|
|||
Formula |
C60H90N6O14
|
|||
Canonical SMILES |
CC1C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)O1)CC(C)C)C)CC2=CC=C(C=C2)N3CCOCC3)CC(C)C)C)C)CC(C)C)C)CC4=CC=C(C=C4)N5CCOCC5)CC(C)C)C
|
|||
InChI |
1S/C60H90N6O14/c1-37(2)31-47-57(71)77-41(9)53(67)61(11)50(34-40(7)8)60(74)80-52(36-44-17-21-46(22-18-44)66-25-29-76-30-26-66)56(70)64(14)48(32-38(3)4)58(72)78-42(10)54(68)62(12)49(33-39(5)6)59(73)79-51(55(69)63(47)13)35-43-15-19-45(20-16-43)65-23-27-75-28-24-65/h15-22,37-42,47-52H,23-36H2,1-14H3/t41-,42-,47+,48+,49+,50+,51-,52-/m1/s1
|
|||
InChIKey |
ZMQMTKVVAMWKNY-YSXLEBCMSA-N
|
|||
CAS Number |
CAS 155030-63-0
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:78739
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT03383614) Safety, Tolerability and PK of Multiple-ascending Doses of Emodepside. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.